465 related articles for article (PubMed ID: 24353357)
1. The de ritis ratio: the test of time.
Botros M; Sikaris KA
Clin Biochem Rev; 2013 Nov; 34(3):117-30. PubMed ID: 24353357
[TBL] [Abstract][Full Text] [Related]
2. Biochemical Evaluation of Patients of Alcoholic Liver Disease and Non-alcoholic Liver Disease.
Torkadi PP; Apte IC; Bhute AK
Indian J Clin Biochem; 2014 Jan; 29(1):79-83. PubMed ID: 24478554
[TBL] [Abstract][Full Text] [Related]
3. The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients.
Wang H; Fang K; Zhang J; Jiang Y; Wang G; Zhang H; Chen T; Shi X; Li Y; Duan F; Liu J
Int Urol Nephrol; 2017 Aug; 49(8):1391-1398. PubMed ID: 28550473
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke.
Ahmadabad MA; Naeimi A; Keymoradzadeh A; Faghani S; Ahmadabad MA; Boroujeni NA; Mohammadpour H; Saberi A
BMC Neurol; 2022 Dec; 22(1):450. PubMed ID: 36463106
[TBL] [Abstract][Full Text] [Related]
5. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis.
Williams AL; Hoofnagle JH
Gastroenterology; 1988 Sep; 95(3):734-9. PubMed ID: 3135226
[TBL] [Abstract][Full Text] [Related]
6. De Ritis ratio as diagnostic marker of alcoholic liver disease.
Majhi S; Baral N; Lamsal M; Mehta KD
Nepal Med Coll J; 2006 Mar; 8(1):40-2. PubMed ID: 16827089
[TBL] [Abstract][Full Text] [Related]
7. De Ritis (aspartate transaminase/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy.
Nishikawa M; Miyake H; Fujisawa M
Urol Oncol; 2016 Sep; 34(9):417.e9-417.e15. PubMed ID: 27180325
[TBL] [Abstract][Full Text] [Related]
8. Association of De Ritis Ratio with Prognosis in Patients with Coronary Artery Disease and Aminotransferase Activity within and outside the Healthy Values of Reference Range.
Ndrepepa G; Cassese S; Scalamogna M; Lahu S; Aytekin A; Xhepa E; Schunkert H; Kastrati A
J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176615
[TBL] [Abstract][Full Text] [Related]
9. The reversed De Ritis ratio for predicting in-hospital mortality among intensive care patients with organophosphate poisoning.
Nafea O; Ibrahim F; Abdelhamid W
Biomarkers; 2023 Feb; 28(1):111-117. PubMed ID: 36377078
[TBL] [Abstract][Full Text] [Related]
10. The Elevated De Ritis Ratio on Admission Is Independently Associated with Mortality in COVID-19 Patients.
Drácz B; Czompa D; Müllner K; Hagymási K; Miheller P; Székely H; Papp V; Horváth M; Hritz I; Szijártó A; Werling K
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366457
[TBL] [Abstract][Full Text] [Related]
11. The De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Prognosticator in Patients With End-stage Renal Disease-associated Renal Cell Carcinoma.
Ikeda T; Ishihara H; Takagi T; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Okumi M; Ishida H; Kondo T; Tanabe K
Clin Genitourin Cancer; 2020 Jun; 18(3):236-240.e1. PubMed ID: 31917171
[TBL] [Abstract][Full Text] [Related]
12. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
[TBL] [Abstract][Full Text] [Related]
13. AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations.
Guéchot J; Boisson RC; Zarski JP; Sturm N; Calès P; Lasnier E;
Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):467-72. PubMed ID: 23932706
[TBL] [Abstract][Full Text] [Related]
14. The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients.
Zinellu A; Arru F; De Vito A; Sassu A; Valdes G; Scano V; Zinellu E; Perra R; Madeddu G; Carru C; Pirina P; Mangoni AA; Babudieri S; Fois AG
Eur J Clin Invest; 2021 Jan; 51(1):e13427. PubMed ID: 33043447
[TBL] [Abstract][Full Text] [Related]
15. The utility of De Ritis Ratio in predicting prognosis in testicular cancer.
Guner E; Seker KG; Arikan Y; Huseynov C; Sam E; Ozdal OL
Aktuelle Urol; 2020 Jun; 51(3):285-289. PubMed ID: 32135561
[TBL] [Abstract][Full Text] [Related]
16. Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients.
Wang B; Hu L; Chen Y; Zhu B; Kong W; Zhu Z; Wang K; Yu Q; Zhang W; Wu G; Sun Y; Xia Z
Burns; 2022 Jun; 48(4):872-879. PubMed ID: 34456097
[TBL] [Abstract][Full Text] [Related]
17. De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study.
Yuk HD; Jeong CW; Kwak C; Kim HH; Ku JH
Dis Markers; 2019; 2019():6702964. PubMed ID: 31534562
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study.
Ishihara H; Kondo T; Yoshida K; Omae K; Takagi T; Iizuka J; Tanabe K
Clin Genitourin Cancer; 2017 Oct; 15(5):598-604. PubMed ID: 28495053
[TBL] [Abstract][Full Text] [Related]
19. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
[TBL] [Abstract][Full Text] [Related]
20. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.
Giannini E; Risso D; Botta F; Chiarbonello B; Fasoli A; Malfatti F; Romagnoli P; Testa E; Ceppa P; Testa R
Arch Intern Med; 2003 Jan; 163(2):218-24. PubMed ID: 12546613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
